Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 3,205.00
+215.00 (7.19%)
Feb 3, 2026, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 88.21 billion as of February 2, 2026. Its market cap has decreased by -28.42% in one year.
Market Cap
88.21B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,205.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 88.21B, a decrease of -81.72%. That is a compound annual growth rate of -21.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 88.21B | 4.55% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.20T |
| Celltrion | 45.95T |
| ALTEOGEN | 21.07T |
| ABL Bio | 10.93T |
| Sugentech | 97.09B |
| CG Invites | 95.66B |
| PharmGen Science | 92.25B |
| Amicogen | 91.29B |